1. Pullat GB, Bohrmann B, George GS, Dikshit S, Singh A, Chaturvedi P, Dikshit R, Lewington S, Mhatre S (2026). The impact of tobacco cessation on buccal mucosa cancer risk: A multi-centre case-control study in India. International Journal of Cancer

2. Mohite SU, Panse N, Kannan R, Tapkire R, Pradhan S, Gulia A, Mirgane K, Dhalgade S, Sangale V, Khandagale S, Kadir Laskar A, Das U, Dutta J, Chakraborty T, Pathak R, Krishnatreya M, Pahwa V, Kotkar L, Manjrekar A, Kadam K, George GS, Moirangthem R, Bharmal K, Doibale P, Ostwal V, Shrikhande SV, Kulkarni S, Shetty N, Dikshit R, Chaturvedi P, Mhatre S (2026). Prevalence of gallstone disease in India: insights from a community-based cross-sectional study. BMJ Public Health. 4(1):e004015.

3. P Aswathy, Kannusamy S, Oak A, Prakash G, Joshi A, Murthy V, Menon S, Cheulkar S, Lokhande M, Balasubramaniam G, Dikshit R, Chaturvedi P, Gupta S (2026). Survival outcomes in prostate cancer patients treated at an Indian tertiary care centre. BJUI Compass. ;7(2):e70155

4. Nath S, Hole A, Bagal B, Noothalapati H, Govekar R, CM Krishna (2026). Comparison of biological materials to assess their suitability for Raman spectroscopic detection of chronic myeloid leukemia. Analytical Methods.

5. Mirian C, Jensen LR, Hoffmann AG, Juratli TA, Maier AD, Lindner P, Broechner A, Torp SH, Shih HA, Morshed RA, Young JS, Magill ST, Stummer W, Spille DC, Brokinkel B, Proescholdt M, Kuroi Y, Gousias K, Simon M, Prat-Acin R, Goutagny S, Wach J, Güresir E, Yamamoto J, Kim YZ, Lee JH, Kim DW, Koshy M, Cannon DM, Shrieve DC, Suh CO, Chang JH, Kamenova M, Straumann S, Soleman J, Eyüpoglu IY, Catalan T, Lui A, Theodosopoulos PV, McDermott MW, Góes P, Wang F, Souhami L, Guiot MC, Csonka T, Endo T, Gupta T, Patel AJ, Klisch TJ, Kim JW, Maiuri F, Barresi V, Tabernero MD, Skyrman S, Krause M, Law I, Kristensen BW, Munch TN, Meling T, Fugleholm K, Blanche P, Mathiesen T (2026). Fractionated radiotherapy adjuvant to surgery of WHO-2 meningioma with and without gross total resection: a multicenter, retrospective cohort study of 1,452 patients. Journal of Neuro-oncology. 176(3):201

6. Krishnan A, Baviskar Y, Chatterjee A, Dasgupta A, Epari S, Sahu A, Chinnaswamy G, Menon N, Moiyadi A, Gupta T, Goda J (2026). Presentation and outcomes of CNS tumors associated with phakomatoses syndromes from a specialized Neuro-Oncology practice in India. Cancer Medicine.

7. Singh VP, Bhardwaj H, Shakthi Devan RK, Thorat R (2025). Building a humane scientific future: Second Asia Laboratory Animal Day. Animal Models and Experimental Medicine. 8(12):2178-2179

8. Gera P, Chavan P, Kamtalwar S, More A, Jadhav V, Parikh P, Haralkar S, Mohite R, Patil M, Samal R, Sarin R, Pagdhune A (2026). A Variant in the TSH β Gene Resulted in Discordant TSH Levels in an Indian Patient. The electronic Journal of the International Federation of Clinical Chemistry and Laboratory Medicine. 37(1):171-176.

9. Maity A, Kumar R, Dutta M, Mishra A, Gawde J, Patil J, Kadam D, Mirgh S, Gokarn A, Jain H, Nayak L, Bagal B, Punatar S, Sengar M, Khattry N, Subramanian PG, Tembhare P, Hasan SK (2026). TGFβ-mediated overexpression of podoplanin serves as a potential diagnostic biomarker in acute promyelocytic leukemia. Molecular Carcinogenesis.

10. Begum SN, Hasan SK (2026). Prime editing driven functional genomics: Bridging genotype to phenotype in the post-genomic era. International Journal of Molecular Sciences. 27(4):1703

11. Dasgupta A, Ghosh S, Chatterjee A, Kannan S, Goswami S, Ranjith CP, Punde R, Meena L, Shinde P, Konthoujam M, Phurailatpam R, Sutar A, Patil D, Sahu A, Sridhar E, Moiyadi A, Menon N, Puranik A, Bano N, Gupta T (2026). Proton versus photon radiotherapy in adults with primary brain tumors evaluating functional survival: a phase 3 randomized controlled trial study protocol (PRIDE). Radiation Oncology.

12. Corbeau A, Spampinato S, Charnalia M, Ranjan N, Gupta S, Kannan S, Dora T, Engineer R, Maheshwari A, Mittal P, Jain J, Gupta A, Panda S, Ghosh J, Sawant P, de Boer S, Hoogeman M, Nout R, Chopra S (2026). Normal tissue complication probability models for gastrointestinal toxicity after adjuvant (chemo)radiotherapy for cervical cancer in the PARCER trial, Radiotherapy and Oncology.

13. Nagar A, Samanta A, Chopra S, Mittal P, Gupta A, Jain J, Ghadi Y, Panda S, Rane P, Sawant P, Rath S, Ghosh J, Gupta S. (2026)CT vs. MRI for image-guided brachytherapy in locally advanced cervical cancer: A Propensity Score Matched Analysis. International Journal of Radiation Oncology,Biology,Physics.

14. Chopra S, Mittal P, Gupta A, Goda JS, Pai V, Kannan S, Menon S, Deodhar K, Jain J, Sawant S, Wairkar T, Sawant S, Thakkar P, Nookala M, Ghosh J, Rath S, Popat P, Rangarajan V, Gota V, Gupta S (2026). Chemoradiation and image-guided brachytherapy alone or in combination with protease inhibitor (Nelfinavir Mesylate) in stage III cervical cancer: Results from a phase III trial. JCO Oncology Advances

Book Chapter
Laskar SG, Kumar A, Sinha S, Mohanty S(2026). External Beam Radiation Therapy in Thyroid Cancer. In: Pai, PS, Ito Y, Shaha AR, de Souza C. (eds) Controversies in Cancer of the Thyroid and Parathyroid Glands. Springer. Pp. 281-292

The Human Protein Atlas consists of nine separate resources, each focusing on a particular aspect of the genome-wide analysis of the human proteins

Mecklenbrauck R, Villaverde Ramiro A, Sträng E, Gabdoulline R, Martinez Elicegui J, Sobas M, Pleyer L, Turki A, Voso MT, Benner A, Hernández-Sánchez A, Tettero JM, Tur Gimenez L, Metzeler KH, Oñate G, Lehmann S, Huntly BJ, Thomas I, Thol FR, Heidel FH, Valk PJ, Döhner K, Haferlach T, Mills KI, Döhner H, Castellani G, Ossenkoppele GJ, Hernández-Rivas JM, Bullinger L, Heuser M (2026). Prognostic impact of myelodysplasia-related gene mutations in FLT3-ITD-mutated acute myeloid leukemia. Leukemia.

In 2001, Results of a clinical trial showed that the drug imatinib mesylate, which targets a unique protein produced by the Philadelphia chromosome, is effective against chronic myelogenous leukemia (CML).

2026 Advanced Centre for Treatment, Research and Education in Cancer (ACTREC)